Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD),Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry),End User (Hospitals) - Global Forecast to 2026
The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3% during the forecast period. The rapid growth in the newborn screening rate, the increasing prevalence of newborn metaboloic, hormonal and genetic diseases, and favourable government policies are driving the growth of the newborn screening.
“newborn Disorder screening instruments segment accounted for the largest share of newborn screening market in 2019.”
Based on instrument, the newborn screening market is segmented into newborn disorder screening instruments, newborn hearing screening instruments, and pulse oximeters. Newborn disorder screening instruments accounted for the largest share in 2019. These instruments can screen for the majority of newborn disorders and thus see the highest demand. Government support and the implementation of newborn screening programs also support the market.
“Dry blood spot tests accounted for the largest share of the newborn screening market in 2019.”
The newborn screening market, by test, is segmented into dry blood spot tests, hearing screening tests, and critical congenital heart defect (CCHD) screening tests. In 2019, the dry blood spot tests segment accounted for the largest share of the newborn screening market due to the wide acceptance of dry blood spot tests for screening disorders. Most metabolic, hormonal, and genetic disorders are diagnosed using dry blood spot tests.
“Asia Pacific estimated to register the highest CAGR during the forecast period.”
In this report, the newborn screening market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to grow at the highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of a large pool of newborn, increasing prevalence of newborn disorders, incresing awareness abou early diagnosis of disease, and rising focus of key players in this region.
Breakdown of primary supply-side interviews, by company type, designation, and region:
1. PerkinElmer (US)
2. Demant A/S (Denmark)
3. Natus Medical (US)
4. Bio-Rad Laboratories (US)
5. Danaher Corporation (US)
6. Medtronic (Ireland)
7. Chromsystems Instruments & Chemicals GmbH (Germany)
8. Trivitron Healthcare (India)
9. Baebies (US)
10. Parseq Lab (Russia)
11. Recipe Chemicals+Instruments (Germany)
12. Bio-Rad Laboratories (US)
13. Zivak Technology (Turkey)
14. Demant (Denmark)
15. CAMAG (Switzerland)
16. Otodynamics Ltd (UK)
17. Zentech S.A. (Belgium)
18. Hill-Rom Holdings (US)
19. Intelligent Hearing Systems Corp (US)
20. Waters (US)
21. Thermo Fischer Scientific (US)
22. MP Biomedicals (US)
23. CENTOGENE N.V. (Germany)
24. DRG International (US)
25. Regis Technologies (US).
Research Coverage
This report studies the newborn screening market based on product and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total newborn screening market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
“newborn Disorder screening instruments segment accounted for the largest share of newborn screening market in 2019.”
Based on instrument, the newborn screening market is segmented into newborn disorder screening instruments, newborn hearing screening instruments, and pulse oximeters. Newborn disorder screening instruments accounted for the largest share in 2019. These instruments can screen for the majority of newborn disorders and thus see the highest demand. Government support and the implementation of newborn screening programs also support the market.
“Dry blood spot tests accounted for the largest share of the newborn screening market in 2019.”
The newborn screening market, by test, is segmented into dry blood spot tests, hearing screening tests, and critical congenital heart defect (CCHD) screening tests. In 2019, the dry blood spot tests segment accounted for the largest share of the newborn screening market due to the wide acceptance of dry blood spot tests for screening disorders. Most metabolic, hormonal, and genetic disorders are diagnosed using dry blood spot tests.
“Asia Pacific estimated to register the highest CAGR during the forecast period.”
In this report, the newborn screening market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to grow at the highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of a large pool of newborn, increasing prevalence of newborn disorders, incresing awareness abou early diagnosis of disease, and rising focus of key players in this region.
Breakdown of primary supply-side interviews, by company type, designation, and region:
- By Company Type: Tier 1 (70%) , Tier 2 (20%), and Tier 3 (10%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (35%), Europe (24%), Asia Pacific (25%), and Rest of the World (16%)
1. PerkinElmer (US)
2. Demant A/S (Denmark)
3. Natus Medical (US)
4. Bio-Rad Laboratories (US)
5. Danaher Corporation (US)
6. Medtronic (Ireland)
7. Chromsystems Instruments & Chemicals GmbH (Germany)
8. Trivitron Healthcare (India)
9. Baebies (US)
10. Parseq Lab (Russia)
11. Recipe Chemicals+Instruments (Germany)
12. Bio-Rad Laboratories (US)
13. Zivak Technology (Turkey)
14. Demant (Denmark)
15. CAMAG (Switzerland)
16. Otodynamics Ltd (UK)
17. Zentech S.A. (Belgium)
18. Hill-Rom Holdings (US)
19. Intelligent Hearing Systems Corp (US)
20. Waters (US)
21. Thermo Fischer Scientific (US)
22. MP Biomedicals (US)
23. CENTOGENE N.V. (Germany)
24. DRG International (US)
25. Regis Technologies (US).
Research Coverage
This report studies the newborn screening market based on product and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total newborn screening market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the newborn screening offered by the top 10 players in the market. The report analyzes the newborn screening market by product and region
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various newborn screening across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the newborn screening market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the newborn screening market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.4.2 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
1.9 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: PATIENT-BASED METHODOLOGY
2.2.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 NEWBORN SCREENING MARKET, BY PRODUCT, 2021 VS. 2026
FIGURE 8 NEWBORN SCREENING INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026
FIGURE 9 NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021 VS. 2026
FIGURE 10 NEWBORN SCREENING MARKET, BY TEST, 2021 VS. 2026
FIGURE 11 NEWBORN SCREENING MARKET, BY END USER, 2021 VS. 2026
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE NEWBORN SCREENING MARKET
4 PREMIUM INSIGHTS
4.1 NEWBORN SCREENING MARKET OVERVIEW
FIGURE 13 FAVORABLE GOVERNMENT POLICIES AND AVAILABILITY OF NEWBORN SCREENING PROGRAMS TO SUPPORT THE NEWBORN SCREENING MARKET
4.2 NEWBORN SCREENING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 14 CONSUMABLES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
4.3 NORTH AMERICAN NEWBORN SCREENING MARKET, BY PRODUCT AND COUNTRY
FIGURE 15 US DOMINATES THE NEWBORN SCREENING MARKET
4.4 NEWBORN SCREENING MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 NEWBORN SCREENING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of newborn disorders
5.2.1.2 Newborn screening programs and legislation
5.2.1.3 Favorable reimbursement policies
5.2.2 OPPORTUNITIES
5.2.2.1 Growth potential of emerging economies
5.2.3 CHALLENGES
5.2.3.1 Availability of refurbished products
5.3 COVID-19 IMPACT ON NEWBORN SCREENING
5.4 PRICING ANALYSIS
5.5 PATENT ANALYSIS
5.6 TRADE ANALYSIS
5.6.1 TRADE ANALYSIS FOR SPECTROMETERS
TABLE 1 EXPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS AND SPECTROGRAPHS USING OPTICAL RADIATIONS, SUCH AS UV, VISIBLE, IR, BY COUNTRY, 2016—2020 (USD MILLION)
TABLE 2 IMPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS AND SPECTROGRAPHS USING OPTICAL RADIATIONS, SUCH AS UV, VISIBLE, IR, BY COUNTRY, 2016—2020 (USD MILLION)
5.7 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 19 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR
PROMINENT COMPANIES
5.9 ECOSYSTEM ANALYSIS
5.10 TECHNOLOGY ANALYSIS
5.11 PESTLE ANALYSIS
5.12 REGULATORY LANDSCAPE
FIGURE 20 510(K) APPROVAL PROCESS
5.13 PORTER’S FIVE ANALYSIS
FIGURE 21 NEWBORN SCREENING MARKET, PORTER’S FIVE ANALYSIS
6 NEWBORN SCREENING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 3 NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 4 NEWBORN SCREENING CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 ASSAY KITS & REAGENTS
6.2.1.1 Assay kits & reagents hold the largest share of the
consumables market
TABLE 5 ASSAY KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 OTHER CONSUMABLES
TABLE 6 OTHER NEWBORN SCREENING CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 7 NEWBORN SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 NEWBORN DISORDER SCREENING INSTRUMENTS
TABLE 8 NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 9 NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1.1 Fully automated instruments
6.3.1.1.1 Fully automated instruments dominate the disorder screening instruments market
TABLE 10 FULLY AUTOMATED INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1.2 Other instruments
TABLE 11 OTHER NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 NEWBORN HEARING SCREENING INSTRUMENTS
TABLE 12 NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 13 NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2.1 Accessories
6.3.2.1.1 The accessories segment dominates the hearing screening instruments market
TABLE 14 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2.2 Devices
6.3.2.2.1 Government recommendations ensure sustained demand for hearing screening devices
TABLE 15 DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 PULSE OXIMETERS
6.3.3.1 The high prevalence of CCHD and recommendations for pulse oximetry testing drive the market growth
TABLE 16 PULSE OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
7 NEWBORN SCREENING MARKET, BY TEST
7.1 INTRODUCTION
TABLE 17 NEWBORN SCREENING MARKET, BY TEST, 2018–2026 (USD MILLION)
7.2 DRY BLOOD SPOT TESTS
7.2.1 DRY BLOOD SPOT TESTS DOMINATE THE NEWBORN SCREENING MARKET
TABLE 18 NEWBORN DRY BLOOD SPOT TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3 HEARING SCREENING TESTS
7.3.1 RECOMMENDATIONS FROM GOVERNMENT ORGANIZATIONS TO
SUPPORT THE MARKET GROWTH
TABLE 19 NEWBORN HEARING SCREENING TESTS MARKET, BY REGION, 2018–2026 (USD MILLION)
7.4 CRITICAL CONGENITAL HEART DEFECT SCREENING TESTS
7.4.1 APAC TO SHOW RISING DEMAND FOR CCHD SCREENING TESTS
TABLE 20 NEWBORN CCHD SCREENING TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
8 NEWBORN SCREENING MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
TABLE 21 NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
8.2 IMMUNOASSAYS & ENZYMATIC ASSAYS
8.2.1 ENZYMATIC AND IMMUNOASSAYS DOMINATE THE NEWBORN SCREENING MARKET, BY TECHNOLOGY
TABLE 22 NEWBORN SCREENING MARKET FOR IMMUNOASSAYS & ENZYMATIC ASSAYS, BY REGION, 2019–2026 (USD MILLION)
8.3 TANDEM MASS SPECTROMETRY
8.3.1 NORTH AMERICA HOLDS THE LARGEST SHARE OF THE TANDEM MASS SPECTROMETRY MARKET
TABLE 23 NEWBORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY, BY REGION, 2018–2026 (USD MILLION)
8.4 MOLECULAR ASSAYS
8.4.1 RISING NUMBER OF SEVERE COMBINED IMMUNODEFICIENCY CASES IN NEWBORNS TO SUPPORT THE MARKET GROWTH
TABLE 24 NEWBORN SCREENING MARKET FOR MOLECULAR ASSAYS, BY REGION, 2018–2026 (USD MILLION)
8.5 HEARING SCREENING TECHNOLOGIES
8.5.1 APAC EXPECTED TO REGISTER HIGHEST GROWTH RATE IN THIS MARKET
TABLE 25 NEWBORN SCREENING MARKET FOR HEARING SCREENING TECHNOLOGIES, BY REGION, 2018–2026 (USD MILLION)
8.6 PULSE OXIMETRY
8.6.1 INCREASING PREVALENCE OF CCHD TO SUPPORT THE MARKET GROWTH
TABLE 26 NEWBORN SCREENING MARKET FOR PULSE OXIMETRY, BY REGION, 2018–2026 (USD MILLION)
8.7 OTHER TECHNOLOGIES
TABLE 27 OTHER NEWBORN SCREENING TECHNOLOGIES MARKET, BY REGION, 2018–2026 (USD MILLION)
9 NEWBORN SCREENING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 28 NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 CLINICAL LABORATORIES
9.2.1 PRESENCE OF SKILLED PROFESSIONAL AND ROBUST INFRASTRUCTURE TO SUPPORT THE MARKET GROWTH
TABLE 29 NEWBORN SCREENING MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018–2026 (USD MILLION)
9.3 HOSPITALS
9.3.1 NORTH AMERICA DOMINATES THE HOSPITALS SEGMENT
TABLE 30 NEWBORN SCREENING MARKET FOR HOSPITALS, BY REGION, 2018–2026 (USD MILLION)
10 NEWBORN SCREENING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 31 NEWBORN SCREENING MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: NEWBORN SCREENING MARKET SNAPSHOT
TABLE 32 NORTH AMERICA: NEWBORN SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 33 NORTH AMERICA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 34 NORTH AMERICA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 NORTH AMERICA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Availability of reimbursement in the country is expected to support the market growth
TABLE 41 US: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 42 US: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 US: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 44 US: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 US: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 46 US: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 47 US: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 48 US: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Investments for newborn screening in Canada to
support market growth
TABLE 49 CANADA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 50 CANADA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 51 CANADA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 CANADA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 CANADA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 54 CANADA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 55 CANADA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 56 CANADA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 57 EUROPE: NEWBORN SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 58 EUROPE: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany holds the largest share of the European
newborn screening market
TABLE 66 GERMANY: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 GERMANY: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 GERMANY: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 GERMANY: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 72 GERMANY: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 73 GERMANY: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 France accounted for the second-largest market share in Europe
TABLE 74 FRANCE: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 FRANCE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 FRANCE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 FRANCE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 FRANCE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 79 FRANCE: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 80 FRANCE: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 81 FRANCE: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.3 UK
10.3.3.1 Favorable initiatives and reimbursement scenario indicate strong prospects for market growth
TABLE 82 UK: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 UK: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 UK: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 UK: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 UK: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 UK: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 88 UK: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 89 UK: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.4 SPAIN
10.3.4.1 Availability of health insurance to support the market
growth in the country
TABLE 90 SPAIN: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 91 SPAIN: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 SPAIN: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 SPAIN: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 SPAIN: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 SPAIN: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Amendments by the Italian government support newborn
screening in the country
TABLE 98 ITALY: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 ITALY: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 ITALY: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 ITALY: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 ITALY: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 ITALY: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 104 ITALY: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 105 ITALY: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 106 ROE: HEALTH EXPENDITURE (% OF GDP), 2010–2017
TABLE 107 ROE: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 108 ROE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ROE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ROE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ROE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ROE: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 113 ROE: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 114 ROE: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
TABLE 115 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 116 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 117 ASIA PACIFIC: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 122 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 123 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China dominates the newborn screening market in the APAC
TABLE 124 CHINA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 125 CHINA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 CHINA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 CHINA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 128 CHINA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 CHINA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 130 CHINA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 131 CHINA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising testing volumes and growing healthcare expenditure
drive the market
TABLE 132 JAPAN: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 JAPAN: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 JAPAN: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 JAPAN: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 JAPAN: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 JAPAN: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 138 JAPAN: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 139 JAPAN: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 AUSTRALIA
10.4.3.1 Favorable government policies in the country drive the
growth of the market
TABLE 140 AUSTRALIA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 141 AUSTRALIA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 AUSTRALIA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 AUSTRALIA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 AUSTRALIA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 AUSTRALIA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 146 AUSTRALIA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 147 AUSTRALIA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 148 ROAPAC: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 149 ROAPAC: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 ROAPAC: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 ROAPAC: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 ROAPAC: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 ROAPAC: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 154 ROAPAC: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 155 ROAPAC: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 156 ROW: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 157 ROW: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 ROW: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 ROW: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 ROW: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 ROW: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 162 ROW: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 163 ROW: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 23 KEY DEVELOPMENTS IN THE NEWBORN SCREENING MARKET, JANUARY 2017–NOVEMBER 2020
FIGURE 24 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO JANUARY 2021
11.2 MARKET SHARE ANALYSIS
FIGURE 25 NEWBORN SCREENING MARKET SHARE ANALYSIS, 2019
11.3 COMPANY EVALUATION MATRIX
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE PLAYERS
11.3.4 PARTICIPANTS
FIGURE 26 VENDOR DIVE: NEWBORN SCREENING MARKET
11.4 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
11.4.1 PROGRESSIVE COMPANIES
11.4.2 STARTING BLOCKS
11.4.3 RESPONSIVE COMPANIES
11.4.4 DYNAMIC COMPANIES
FIGURE 27 VENDOR DIVE MATRIX FOR START-UPS: NEWBORN SCREENING MARKET
11.5 COMPETITIVE SCENARIO
11.5.1 PRODUCT LAUNCHES & APPROVALS
TABLE 164 NEWBORN SCREENING MARKET: PRODUCT LAUNCHES &
APPROVALS, 2017–2021
11.5.2 DEALS
TABLE 165 NEWBORN SCREENING MARKET: DEALS 2017–2021
11.5.3 OTHER DEVELOPMENTS
TABLE 166 NEWBORN SCREENING MARKET: OTHER DEVELOPMENTS, 2017–2021
FIGURE 28 PRODUCT BENCHMARKING
FIGURE 29 GEOGRAPHIC ASSESSMENT
12 COMPANY PROFILES
12.1 MAJOR PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1.1 PERKINELMER
FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019)
12.1.2 DEMANT
FIGURE 31 DEMANT A/S: COMPANY SNAPSHOT (2019)
12.1.3 NATUS MEDICAL
FIGURE 32 NATUS MEDICAL: COMPANY SNAPSHOT (2019)
12.1.4 MASIMO
FIGURE 33 MASIMO: COMPANY SNAPSHOT (2019)
12.1.5 AB SCIEX
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
12.1.6 MEDTRONIC
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2019)
12.1.7 BAEBIES
12.1.8 INTELLIGENT HEARING SYSTEMS CORP.
12.1.9 WELCH ALLYN
FIGURE 36 HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2019)
12.1.10 WATERS CORPORATION
12.1.11 THERMO FISHER SCIENTIFIC
12.1.12 TRIVITRON HEALTHCARE
12.2 START-UPS/SME PLAYERS
12.2.1 BIO-RAD LABORATORIES
FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
12.2.2 CHROMSYSTEMS INSTRUMENTS & CHEMICALS
12.2.3 PARSEQ LAB
12.2.4 RECIPE CHEMICALS + INSTRUMENTS GMBH
12.2.5 ZIVAK TECHNOLOGIES
12.2.6 CAMAG
12.2.7 OTODYNAMICS
12.2.8 ZENTECH
12.2.9 VIVOSONIC
12.2.10 MP BIOMEDICALS
12.2.11 CENTOGENE
12.2.12 DRG INTERNATIONAL
12.2.13 REGIS TECHNOLOGIES
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.4.2 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
1.9 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: PATIENT-BASED METHODOLOGY
2.2.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 NEWBORN SCREENING MARKET, BY PRODUCT, 2021 VS. 2026
FIGURE 8 NEWBORN SCREENING INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026
FIGURE 9 NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021 VS. 2026
FIGURE 10 NEWBORN SCREENING MARKET, BY TEST, 2021 VS. 2026
FIGURE 11 NEWBORN SCREENING MARKET, BY END USER, 2021 VS. 2026
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE NEWBORN SCREENING MARKET
4 PREMIUM INSIGHTS
4.1 NEWBORN SCREENING MARKET OVERVIEW
FIGURE 13 FAVORABLE GOVERNMENT POLICIES AND AVAILABILITY OF NEWBORN SCREENING PROGRAMS TO SUPPORT THE NEWBORN SCREENING MARKET
4.2 NEWBORN SCREENING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 14 CONSUMABLES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
4.3 NORTH AMERICAN NEWBORN SCREENING MARKET, BY PRODUCT AND COUNTRY
FIGURE 15 US DOMINATES THE NEWBORN SCREENING MARKET
4.4 NEWBORN SCREENING MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 NEWBORN SCREENING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of newborn disorders
5.2.1.2 Newborn screening programs and legislation
5.2.1.3 Favorable reimbursement policies
5.2.2 OPPORTUNITIES
5.2.2.1 Growth potential of emerging economies
5.2.3 CHALLENGES
5.2.3.1 Availability of refurbished products
5.3 COVID-19 IMPACT ON NEWBORN SCREENING
5.4 PRICING ANALYSIS
5.5 PATENT ANALYSIS
5.6 TRADE ANALYSIS
5.6.1 TRADE ANALYSIS FOR SPECTROMETERS
TABLE 1 EXPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS AND SPECTROGRAPHS USING OPTICAL RADIATIONS, SUCH AS UV, VISIBLE, IR, BY COUNTRY, 2016—2020 (USD MILLION)
TABLE 2 IMPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS AND SPECTROGRAPHS USING OPTICAL RADIATIONS, SUCH AS UV, VISIBLE, IR, BY COUNTRY, 2016—2020 (USD MILLION)
5.7 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 19 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR
PROMINENT COMPANIES
5.9 ECOSYSTEM ANALYSIS
5.10 TECHNOLOGY ANALYSIS
5.11 PESTLE ANALYSIS
5.12 REGULATORY LANDSCAPE
FIGURE 20 510(K) APPROVAL PROCESS
5.13 PORTER’S FIVE ANALYSIS
FIGURE 21 NEWBORN SCREENING MARKET, PORTER’S FIVE ANALYSIS
6 NEWBORN SCREENING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 3 NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 4 NEWBORN SCREENING CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 ASSAY KITS & REAGENTS
6.2.1.1 Assay kits & reagents hold the largest share of the
consumables market
TABLE 5 ASSAY KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 OTHER CONSUMABLES
TABLE 6 OTHER NEWBORN SCREENING CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 7 NEWBORN SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 NEWBORN DISORDER SCREENING INSTRUMENTS
TABLE 8 NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 9 NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1.1 Fully automated instruments
6.3.1.1.1 Fully automated instruments dominate the disorder screening instruments market
TABLE 10 FULLY AUTOMATED INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1.2 Other instruments
TABLE 11 OTHER NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 NEWBORN HEARING SCREENING INSTRUMENTS
TABLE 12 NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 13 NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2.1 Accessories
6.3.2.1.1 The accessories segment dominates the hearing screening instruments market
TABLE 14 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2.2 Devices
6.3.2.2.1 Government recommendations ensure sustained demand for hearing screening devices
TABLE 15 DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 PULSE OXIMETERS
6.3.3.1 The high prevalence of CCHD and recommendations for pulse oximetry testing drive the market growth
TABLE 16 PULSE OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
7 NEWBORN SCREENING MARKET, BY TEST
7.1 INTRODUCTION
TABLE 17 NEWBORN SCREENING MARKET, BY TEST, 2018–2026 (USD MILLION)
7.2 DRY BLOOD SPOT TESTS
7.2.1 DRY BLOOD SPOT TESTS DOMINATE THE NEWBORN SCREENING MARKET
TABLE 18 NEWBORN DRY BLOOD SPOT TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3 HEARING SCREENING TESTS
7.3.1 RECOMMENDATIONS FROM GOVERNMENT ORGANIZATIONS TO
SUPPORT THE MARKET GROWTH
TABLE 19 NEWBORN HEARING SCREENING TESTS MARKET, BY REGION, 2018–2026 (USD MILLION)
7.4 CRITICAL CONGENITAL HEART DEFECT SCREENING TESTS
7.4.1 APAC TO SHOW RISING DEMAND FOR CCHD SCREENING TESTS
TABLE 20 NEWBORN CCHD SCREENING TESTS MARKET, BY REGION, 2019–2026 (USD MILLION)
8 NEWBORN SCREENING MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
TABLE 21 NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
8.2 IMMUNOASSAYS & ENZYMATIC ASSAYS
8.2.1 ENZYMATIC AND IMMUNOASSAYS DOMINATE THE NEWBORN SCREENING MARKET, BY TECHNOLOGY
TABLE 22 NEWBORN SCREENING MARKET FOR IMMUNOASSAYS & ENZYMATIC ASSAYS, BY REGION, 2019–2026 (USD MILLION)
8.3 TANDEM MASS SPECTROMETRY
8.3.1 NORTH AMERICA HOLDS THE LARGEST SHARE OF THE TANDEM MASS SPECTROMETRY MARKET
TABLE 23 NEWBORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY, BY REGION, 2018–2026 (USD MILLION)
8.4 MOLECULAR ASSAYS
8.4.1 RISING NUMBER OF SEVERE COMBINED IMMUNODEFICIENCY CASES IN NEWBORNS TO SUPPORT THE MARKET GROWTH
TABLE 24 NEWBORN SCREENING MARKET FOR MOLECULAR ASSAYS, BY REGION, 2018–2026 (USD MILLION)
8.5 HEARING SCREENING TECHNOLOGIES
8.5.1 APAC EXPECTED TO REGISTER HIGHEST GROWTH RATE IN THIS MARKET
TABLE 25 NEWBORN SCREENING MARKET FOR HEARING SCREENING TECHNOLOGIES, BY REGION, 2018–2026 (USD MILLION)
8.6 PULSE OXIMETRY
8.6.1 INCREASING PREVALENCE OF CCHD TO SUPPORT THE MARKET GROWTH
TABLE 26 NEWBORN SCREENING MARKET FOR PULSE OXIMETRY, BY REGION, 2018–2026 (USD MILLION)
8.7 OTHER TECHNOLOGIES
TABLE 27 OTHER NEWBORN SCREENING TECHNOLOGIES MARKET, BY REGION, 2018–2026 (USD MILLION)
9 NEWBORN SCREENING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 28 NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 CLINICAL LABORATORIES
9.2.1 PRESENCE OF SKILLED PROFESSIONAL AND ROBUST INFRASTRUCTURE TO SUPPORT THE MARKET GROWTH
TABLE 29 NEWBORN SCREENING MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018–2026 (USD MILLION)
9.3 HOSPITALS
9.3.1 NORTH AMERICA DOMINATES THE HOSPITALS SEGMENT
TABLE 30 NEWBORN SCREENING MARKET FOR HOSPITALS, BY REGION, 2018–2026 (USD MILLION)
10 NEWBORN SCREENING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 31 NEWBORN SCREENING MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: NEWBORN SCREENING MARKET SNAPSHOT
TABLE 32 NORTH AMERICA: NEWBORN SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 33 NORTH AMERICA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 34 NORTH AMERICA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 35 NORTH AMERICA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Availability of reimbursement in the country is expected to support the market growth
TABLE 41 US: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 42 US: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 US: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 44 US: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 45 US: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 46 US: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 47 US: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 48 US: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Investments for newborn screening in Canada to
support market growth
TABLE 49 CANADA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 50 CANADA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 51 CANADA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 52 CANADA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 CANADA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 54 CANADA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 55 CANADA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 56 CANADA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 57 EUROPE: NEWBORN SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 58 EUROPE: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany holds the largest share of the European
newborn screening market
TABLE 66 GERMANY: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 GERMANY: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 GERMANY: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 GERMANY: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 72 GERMANY: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 73 GERMANY: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 France accounted for the second-largest market share in Europe
TABLE 74 FRANCE: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 FRANCE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 FRANCE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 FRANCE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 FRANCE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 79 FRANCE: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 80 FRANCE: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 81 FRANCE: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.3 UK
10.3.3.1 Favorable initiatives and reimbursement scenario indicate strong prospects for market growth
TABLE 82 UK: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 UK: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 UK: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 UK: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 UK: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 UK: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 88 UK: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 89 UK: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.4 SPAIN
10.3.4.1 Availability of health insurance to support the market
growth in the country
TABLE 90 SPAIN: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 91 SPAIN: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 SPAIN: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 SPAIN: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 SPAIN: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 SPAIN: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Amendments by the Italian government support newborn
screening in the country
TABLE 98 ITALY: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 ITALY: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 ITALY: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 ITALY: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 ITALY: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 ITALY: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 104 ITALY: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 105 ITALY: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 106 ROE: HEALTH EXPENDITURE (% OF GDP), 2010–2017
TABLE 107 ROE: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 108 ROE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ROE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ROE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ROE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ROE: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 113 ROE: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 114 ROE: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
TABLE 115 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 116 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 117 ASIA PACIFIC: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 122 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 123 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China dominates the newborn screening market in the APAC
TABLE 124 CHINA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 125 CHINA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 CHINA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 CHINA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 128 CHINA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 CHINA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 130 CHINA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 131 CHINA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising testing volumes and growing healthcare expenditure
drive the market
TABLE 132 JAPAN: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 JAPAN: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 JAPAN: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 JAPAN: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 JAPAN: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 JAPAN: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 138 JAPAN: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 139 JAPAN: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 AUSTRALIA
10.4.3.1 Favorable government policies in the country drive the
growth of the market
TABLE 140 AUSTRALIA: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 141 AUSTRALIA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 AUSTRALIA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 AUSTRALIA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 AUSTRALIA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 AUSTRALIA: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 146 AUSTRALIA: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 147 AUSTRALIA: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 148 ROAPAC: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 149 ROAPAC: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 ROAPAC: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 ROAPAC: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 ROAPAC: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 ROAPAC: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 154 ROAPAC: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 155 ROAPAC: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 156 ROW: NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 157 ROW: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 ROW: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 ROW: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 ROW: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 ROW: NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 162 ROW: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION)
TABLE 163 ROW: NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 23 KEY DEVELOPMENTS IN THE NEWBORN SCREENING MARKET, JANUARY 2017–NOVEMBER 2020
FIGURE 24 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO JANUARY 2021
11.2 MARKET SHARE ANALYSIS
FIGURE 25 NEWBORN SCREENING MARKET SHARE ANALYSIS, 2019
11.3 COMPANY EVALUATION MATRIX
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE PLAYERS
11.3.4 PARTICIPANTS
FIGURE 26 VENDOR DIVE: NEWBORN SCREENING MARKET
11.4 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
11.4.1 PROGRESSIVE COMPANIES
11.4.2 STARTING BLOCKS
11.4.3 RESPONSIVE COMPANIES
11.4.4 DYNAMIC COMPANIES
FIGURE 27 VENDOR DIVE MATRIX FOR START-UPS: NEWBORN SCREENING MARKET
11.5 COMPETITIVE SCENARIO
11.5.1 PRODUCT LAUNCHES & APPROVALS
TABLE 164 NEWBORN SCREENING MARKET: PRODUCT LAUNCHES &
APPROVALS, 2017–2021
11.5.2 DEALS
TABLE 165 NEWBORN SCREENING MARKET: DEALS 2017–2021
11.5.3 OTHER DEVELOPMENTS
TABLE 166 NEWBORN SCREENING MARKET: OTHER DEVELOPMENTS, 2017–2021
FIGURE 28 PRODUCT BENCHMARKING
FIGURE 29 GEOGRAPHIC ASSESSMENT
12 COMPANY PROFILES
12.1 MAJOR PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1.1 PERKINELMER
FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019)
12.1.2 DEMANT
FIGURE 31 DEMANT A/S: COMPANY SNAPSHOT (2019)
12.1.3 NATUS MEDICAL
FIGURE 32 NATUS MEDICAL: COMPANY SNAPSHOT (2019)
12.1.4 MASIMO
FIGURE 33 MASIMO: COMPANY SNAPSHOT (2019)
12.1.5 AB SCIEX
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
12.1.6 MEDTRONIC
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2019)
12.1.7 BAEBIES
12.1.8 INTELLIGENT HEARING SYSTEMS CORP.
12.1.9 WELCH ALLYN
FIGURE 36 HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2019)
12.1.10 WATERS CORPORATION
12.1.11 THERMO FISHER SCIENTIFIC
12.1.12 TRIVITRON HEALTHCARE
12.2 START-UPS/SME PLAYERS
12.2.1 BIO-RAD LABORATORIES
FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
12.2.2 CHROMSYSTEMS INSTRUMENTS & CHEMICALS
12.2.3 PARSEQ LAB
12.2.4 RECIPE CHEMICALS + INSTRUMENTS GMBH
12.2.5 ZIVAK TECHNOLOGIES
12.2.6 CAMAG
12.2.7 OTODYNAMICS
12.2.8 ZENTECH
12.2.9 VIVOSONIC
12.2.10 MP BIOMEDICALS
12.2.11 CENTOGENE
12.2.12 DRG INTERNATIONAL
12.2.13 REGIS TECHNOLOGIES
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
The global newborn screening market was valued at an estimated $438.9 million in 2013 and is expected to grow at a CAGR of 11.0% in the next five years. This high growth is mainly attributed to the benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases, and conferences and symposiums related to the usage of new technologies. Furthermore, various awareness programs and conferences are being organized across the globe, which is likely to drive the market growth.
However, factors such as lack of trained professional infrastructure and socio-economic barriers are expected to hinder the market growth.
North America dominates the newborn screening market. Asia is poised to grow at the highest CAGR during the forecast period owing to support provided by foreign countries for enhancing screening services. Apart from this, factors such as increased government support and investment by major players in the region are expected to provide required impetus for the growth of this market.
The prominent players in the newborn screening market are AB SCIEX (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.), PerkinElmer Inc. (U.S.), Trivitron Healthcare (India), and Waters Corporation (U.S.).
